EFFECTS OF COMBINED INSULIN-SULFONYLUREA THERAPY IN TYPE-II PATIENTS

被引：32

作者：

LEWITT, MS ^{[1
]}

YU, VKF ^{[1
]}

RENNIE, GC ^{[1
]}

CARTER, JN ^{[1
]}

MAREL, GM ^{[1
]}

YUE, DKS ^{[1
]}

HOOPER, MJ ^{[1
]}

机构：

[1] REPATRIAT GEN HOSP,DEPT ENDOCRINOL,HOSP RD,CONCORD,NSW 2139,AUSTRALIA

来源：

DIABETES CARE | 1989年 / 12卷 / 06期

关键词：

D O I：

10.2337/diacare.12.6.379

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：379 / 383

页数：5

共 26 条

[1] TREATMENT OF POORLY REGULATED NON-INSULIN-DEPENDENT DIABETES-MELLITUS WITH COMBINATION INSULIN-SULFONYLUREA [J].

ALLEN, BT ;

FEINGLOS, MN ;

LEBOVITZ, HE .

ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (10) :1900-1903

[2]

Anderson J, 1985, Diabet Med, V2, P134

[3] IMPROVED DIABETIC CONTROL IN INSULIN DEPENDENT DIABETICS TREATED WITH INSULIN AND GLIBENCLAMIDE [J].

BURKE, BJ ;

HARTOG, M ;

WATERFIELD, MR .

ACTA ENDOCRINOLOGICA, 1984, 107 (01) :70-77

[4]

BURKE BJ, 1980, ACTA ENDOCRINOL-COP, V95, P373

[5] SENSITIVITY OF INSULIN-SECRETION TO FEEDBACK INHIBITION BY HYPERINSULINEMIA [J].

DEFRONZO, RA ;

BINDER, C ;

WAHREN, J ;

FELIG, P ;

FERRANNINI, E ;

FABER, OK .

ACTA ENDOCRINOLOGICA, 1981, 98 (01) :81-86

[6]

FABER OK, 1982, ACTA ENDOCRINOL S, V274, P21

[7]

FABRYKANT M, 1957, METABOLISM, V6, P509

[8]

FABRYKANT M, 1957, ANN NY ACAD SCI, V82, P585

[9] COMBINATION INSULIN GLYBURIDE THERAPY IN TYPE-II DIABETES-MELLITUS - EFFECTS ON LIPOPROTEIN METABOLISM AND GLUCOREGULATION [J].

FALKO, JM ;

OSEI, K .

AMERICAN JOURNAL OF MEDICINE, 1985, 79 (3B) :92-101

[10]

GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84

← 1 2 3 →